Lanthier L[au] - Search Results

Year	Number of Results
2003	1
2005	1
2007	1
2008	1
2009	2
2010	4
2011	4
2012	1
2013	1
2014	1
2015	1
2016	3
2018	1
2019	2
2020	10
2021	6
2022	2

1

Chez les sujets avec insuffisance cardiaque à fraction d’éjection diminuée avec ou sans diabète de type 2, est-ce que la dapagliflozine, un inhibiteur des SGLT2, est efficace pour prévenir l’insuffisance cardiaque décompensée ou la mortalité cardiovasculaire tout en étant sécuritaire ?

Lanthier L, Dussault C, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 Feb;41(2):143-144. doi: 10.1016/j.revmed.2019.12.011. Epub 2020 Jan 9. Rev Med Interne. 2020. PMID: 31928796 French. No abstract available.

2

[For obese patients or for patients who are overweight and have an associated comorbidity, how safe and effective is semaglutide as compared with placebo as an adjunct to lifestyle intervention for reducing body weight and other related end points?].

Lanthier L, Langlois MF, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 May;42(5):369-370. doi: 10.1016/j.revmed.2021.03.334. Epub 2021 Apr 8. Rev Med Interne. 2021. PMID: 33838950 French. No abstract available.

3

[In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?].

Lanthier L, Carignan A, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 Mar;42(3):227-228. doi: 10.1016/j.revmed.2021.02.001. Epub 2021 Feb 10. Rev Med Interne. 2021. PMID: 33612319 Free PMC article. French. No abstract available.

4

[For patients with heart failure with preserved ejection fraction, is empagliflozine effective and safe for preventing cardiovascular mortality and heart failure hospitalization?].

Lanthier L, Dussault C, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 Nov;42(11):814-815. doi: 10.1016/j.revmed.2021.10.001. Epub 2021 Oct 30. Rev Med Interne. 2021. PMID: 34728091 French. No abstract available.

5

[In patients with moderate chronic kidney disease with albuminuria, including non-diabetic patients, does dapagliflozin provide renal and cardiovascular benefit compared to placebo?].

Lanthier L, Masse M, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 Jan;42(1):65-66. doi: 10.1016/j.revmed.2020.11.008. Epub 2020 Dec 9. Rev Med Interne. 2021. PMID: 33309055 French. No abstract available.

6

[In patients hospitalized for COVID-19 with hypoxia and systemic inflammation, does tocilizumab reduce 28-days mortality compared to standard treatment, and is it safe?].

Lanthier L, Mayette M, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 Jul;42(7):517-518. doi: 10.1016/j.revmed.2021.06.002. Epub 2021 Jun 9. Rev Med Interne. 2021. PMID: 34147258 Free PMC article. French. No abstract available.

7

[In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?].

Lanthier L, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2021 Feb;42(2):144-145. doi: 10.1016/j.revmed.2020.12.013. Epub 2021 Jan 15. Rev Med Interne. 2021. PMID: 33455835 French. No abstract available.

8

[In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?].

Lanthier L, Mayette M, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 Nov;41(11):790-791. doi: 10.1016/j.revmed.2020.08.005. Epub 2020 Oct 9. Rev Med Interne. 2020. PMID: 33077267 Free PMC article. French. No abstract available.

9

[Is screening for lung cancer in high-risk subjects using low-dose CT scan effective in reducing mortality?].

Lanthier L, Bouchard N, Huard G, Plourde ME, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 May;41(5):350-351. doi: 10.1016/j.revmed.2020.04.001. Epub 2020 Apr 17. Rev Med Interne. 2020. PMID: 32312589 French. No abstract available.

10

[In patients with type 2 diabetes and diabetic nephropathy with albuminuria, what is the effect of SGLT2 inhibitor canagliflozin on renal and cardiovascular outcomes?].

Lanthier L, Huard G, Plourde MÉ, Cauchon M. Lanthier L, et al. Rev Med Interne. 2020 Jan;41(1):67-68. doi: 10.1016/j.revmed.2019.11.004. Epub 2019 Dec 4. Rev Med Interne. 2020. PMID: 31812446 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results